Possible mechanisms of the hydralazine‐related lupus‐like syndrome
Open Access
- 1 August 1981
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 24 (8) , 1093-1104
- https://doi.org/10.1002/art.1780240819
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- The role of histones as nuclear autoantigens in drug‐related lupus erythematosusArthritis & Rheumatism, 1981
- B-Lymphocyte Alloantigens Associated with Systemic Lupus ErythematosusNew England Journal of Medicine, 1978
- Survival in hydralazine-treated hypertensive patients with and without late toxicityJournal of Chronic Diseases, 1977
- Return of elevated blood pressure after withdrawal of antihypertensive drugs.Circulation, 1975
- THE COOMBS TEST AND METHYLDOPAThe Lancet, 1968
- ABNORMALITIES OF CIRCULATING CELLS AND PROTEINS IN HYDRALAZINE-TREATED PATIENTS WITHOUT TOXIC SYMPTOMSThe Lancet Healthy Longevity, 1962
- Studies on the Control of HypertensionCirculation, 1956
- Depression of cholesterol levels in human plasma following ethylenediamine tetracetate and hydralazineJournal of Chronic Diseases, 1955
- STUDIES ON THE CONTROL OF HYPERTENSION BY HYPHEX. III. PHARMACOLOGICAL AND CHEMICAL OBSERVATIONS ON 1-HYDRAZINOPHTHALAZINEThe Lancet Healthy Longevity, 1954
- Studies on the Control of Hypertension by HyphexCirculation, 1953